Ripretinib US FDA Label
- Compound: 1-[4-bromo-5-[1-ethyl-7-(methylamino)-2-oxo-1,6-naphthyridin-3-yl]-2-fluorophenyl]-3-phenylurea
- Description: NA
- Brand Name:
- Code(s): DCC-2618
- Approved:
- Kinase Class: RY
- Inhibitor Type: IIA
- Literature (PubMed): 0
- Target(s): KIT proto-oncogene, receptor tyrosine kinase , Platelet derived growth factor receptor alpha , Platelet derived growth factor receptor beta
- Disease(s): gastrointestinal stromal tumor